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ABSTRACT  Indirect  immunofluorescence,  immunoelectron  microscopy,  and  digestion  by  protease 
were used to study intracellular transport of the G protein of vesicular stomatitis virus in mitotic and 
interphase  cells.  Quantitation  showed that the appearance  of G  protein  on the surface  of mitotic 
cells was inhibited at least 10-fold when compared with that on interphase cells, even though similar 
amounts of viral  protein were being synthesized. This dramatic  inhibition,  taken together with the 
simultaneous  inhibition  of endocytosis  (Berlin,  R. D., and J. M. Oliver,  1980, J. Cell Biol.  85:  660- 
671),  points to a general  cessation  of membrane traffic in the mitotic cell. 
Endocytosis is important for the uptake of many nutritional 
and  regulatory proteins (1).  It is exceedingly rapid (2)  and 
occurs  at  all  stages  of the  cell  cycle,  with  the  interesting 
exception of mitosis (3,  4).  The reason for this exception is 
unclear, but it does suggest that endocytosis is incompatible 
with  other  processes involving membranes that  take  place 
during  mitosis. A  study of this  inhibition  might then  lend 
insight not only into these mitotic processes, but also into the 
mechanisms involved in endocytosis. As a first step we have 
sought to generalize this inhibition, since it did not seem likely 
that  the  cell  could  inhibit  endocytosis  and  not  also  other 
pathways of vesicular traffic. We chose to look at intracellular 
transport because it is very well characterized (5), and we have 
used an enveloped animal virus as probe because, in the past, 
these  viruses have greatly facilitated studies  on  membrane 
biogenesis (6).  In this study, we have used the G  protein of 
vesicular  stomatitis  virus  (VSV) j  to  determine  by  several 
techniques whether it reaches the surface of mitotic cells. 
MATERIALS  AND  METHODS 
Immunofluorescence Experiments:  Normal rat kidney  (NRK) 
cells were grown on coverslips (7), infected with ts045 VSV using >50 plaque 
forming units/cell, as previously described for Semliki Forest virus (8). Nocod- 
azole (Sigma Chemical Co., St. Louis, MO) was used at 0.04 ug/ml (9). Cells 
were fixed, labeled (7,  10) with rabbit  anti-(; protein  antibody  (l 1), affinity 
purified on VSV coupled to agarose beads (12), and with an affinity-purified, 
rhodamine-conjugated,  sheep anti-rabbit  IgG (12, 13), and then stained with 
Hoechst dye 33258 (3). 
Experiments Using Isolated,  Mitotic Cells:  The shake-offpro- 
cedure described by Klevecz (14) was used for Chinese hamster ovary (CHO) 
cells grown as a monolayer in ~ minimal essential medium containing  10% 
fetal calf serum, penicillin, and streptomycin. The cells were infected with VSV 
J Abbreviations  used in  this paper.  CHO,  Chinese hamster ovary, 
NRK, normal rat kidney; VSV, vesicular stomatitis virus. 
and treated with nocodazole as described in the text. The isolated, mitotic cells, 
and interphase cells were incubated  in the presence or absence of nocodazole 
and were used either to determine  the amount of viral protein synthesized, by 
quantitative  immunoblotting (15) using purified VSV (11) as standard,  or for 
quantitative immunoelectron microscopy as follows. Thin, frozen sections were 
labeled (16) with anti-G protein  antibody  and protein  A gold (5  nm diam) 
using solutions containing, instead of  gelatin, 10% new-born calf serum, which 
reduced nonspecific labeling to negligible levels. Relative surface labeling was 
quantitated  by standard  stereological procedures  using a transparent  overlay 
containing a lattice test system in order to relate the number of gold particles 
to the number of intersections of  the plasma membrane with the test lines (17). 
Isolated,  mitotic  cells (5  x  10  s cells) were also  labeled with  200  uCi  [35S]- 
methionine  for 30 min at 37"(7, washed, and incubated in medium containing 
0.l  mM  cold  methionine  for  90  min  (8)  in  the  presence  or  absence  of 
nocodazote.  Half the sample was treated  with chymotrypsin  (18), and the G 
protein  was extracted using Triton X-114 (19). Samples were fractionated  by 
SDS PAGE, and labeled proteins were visualized by fluorography (20). 
RESULTS 
Immunofluorescence  Studies  Using NRK Cells 
Infected with  ts045 VSV 
To get infected mitotic cells that are perturbed as little as 
possible by the consequences of viral infection, it is important 
to realise that mitosis cannot be completed if  protein synthesis 
is inhibited more than  l  h  before its onset (21).  VSV shuts 
off host protein synthesis 2-3 h after infection, depending on 
the cell type, and maximal G protein synthesis occurs a little 
later. We found, in preliminary experiments using NRK cells, 
that by limiting the length of any experiment to 3-4 h  we 
were able to get infected mitotic cells that would complete 
mitosis as rapidly as mock-infected cells (Fig.  1) and express 
reasonable amounts of G protein. 
The transport pathway of G protein has been examined in 
detail in CHO cells infected with ts045  VSV (22).  We were 
not  able  to  use  CHO  cells  in  these  immunofluorescence 
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FIGURE  I  Duration of mitosis in  NRK  cells, mock-infected  or in- 
fected with ts045 VSV. After 2 h at 39.5°C and 1 h with nocodazole, 
the latter was removed and the temperature was shifted to 31 °C. 
At different times, cells were fixed and labeled with  Hoechst  dye 
33258  to facilitate the  identification of mitotic cells, and the per- 
centage of those in telophase was determined. 
studies  because,  in  the  mitotic  state,  they were  too  easily 
removed  from  the  coverslip during  the  antibody  labeling 
procedures, ts045 VSV behaved similarly in NRK cells (23) 
as shown in Figs. 2-5. The G protein was not transported to 
the cell surface (Fig.  2G) at the nonpermissive temperature 
of 39.5°C, but remained in the endoplasmic reticulum (Fig. 
3 G).  After  being shifted  to  the  permissive temperature of 
31 °C, the G protein appeared in a perinuclear region contain- 
ing  the  Golgi  complex  (Fig.  5G)  and  on  the  surface  of 
interphase cells (Fig. 4G), where it could be observed as early 
as 15 min after the temperature shift. 
To study G  protein transport in mitotic cells, nocodazole 
was added to prevent spindle assembly (24) with the result 
that cells  entering mitosis were held at an early stage  with 
their chromosomes resembling those of prometaphase cells. 
These mitotic cells had G protein inside (Fig. 3 G) but not on 
FIGURES 2-15  G protein transport in interphase and mitotic NRK cells visualized by indirect immunofluorescence. After infection 
with ts045 VSV, cells were incubated at 39.5°C either for 3 h (Figs. 10-13) or for 2 h and then 1 h in the presence of nocodazole 
(Figs. 2-9,  14,  15). After being transferred to medium free of nocodazole at 31 °C, cells were fixed either immediately (Figs. 2 and 
3), or after 25  min (Figs. 4, 5,  10-15) or 45  min (Figs. 6-9), and then labeled with anti-G  protein antibody before (Figs. 2, 4, 6- 
13) or after (Figs. 3, 5,  14, 15) being permeabilized by Triton X-100. Labeling with a rhodamine-conjugated, sheep anti-rabbit IgG 
was followed by staining with Hoechst dye 33258. Mitotic cells shown here are in prometaphase (Figs. 2, 3, 6), metaphase (Figs. 
7,  10,  14),  early (Fig.  9)  and  late  (Figs.  8,  12,  15)  anaphase, and  early (Fig.  11)  and  late (Fig.  13)  telophase. G:  G  protein,  C; 
chromosomes, N; Nomarski optics. Bar, 20 ~,m. x  1,000. 
1624  RAPID  COMMUNICATIONS R^~,D Co~uN,c^T,o~s  1625 their surface (Fig.  2 G). Removal of the nocodazole allowed 
the arrested cells to continue through mitosis, and they took 
~60  min to reach telophase (Fig.  1). This was significantly 
longer than the 15 min needed for G protein transport to the 
surface of interphase cells. If  nocodazole removal was accom- 
panied by a shift to 3 I'C, the permissive temperature for G 
protein  transport,  we  wondered  whether  G  protein  would 
appear on the  surface of mitotic ceils.  Forty min after the 
temperature shift,  prometaphase, metaphase, and  anaphase 
cells had very little or no surface G protein despite the heavy 
surface  labeling  of neighboring  interphase  cells (Figs.  6-9) 
and the fact that, in parallel experiments, mitotic cells were 
found to have high levels of internal G  protein (Figs.  14 and 
15). The inhibition of transport in mitotic cells was not a side 
effect  of this  drug  because  experiments  performed  in  its 
absence gave identical results (Figs.  10-12). Transport to the 
cell surface resumed in telophase (Fig.  13) though it was not 
too uncommon to find early telophase cells with no surface 
label (Fig.  11). 
The results were presented in a semi-quantitative form by 
scoring  cells  for  surface  label;  the  inhibition  of transport 
during  metaphase and  anaphase  is clearly seen in  Fig.  16. 
Cycloheximide had no effect on this pattern of results, show- 
ing that G  protein synthesized at the nonpermissive temper- 
ature was available for intracellular transport. The degree of 
inhibition  can be calculated by determining the  latest time 
after the temperature shift at which anaphase cells are com- 
monly found (45  min) and dividing this by the earliest time 
at which G  protein appears on the surface of interphase cells 
(15  min). This threefold inhibition is of course a lower esti- 
mate limited by the duration of mitosis and of intracellular 
transport. 
Studies on mitotic CHO  Cells Infected 
with VSV 
To determine whether  the  rate  of intraceUular transport 
was inhibited  by more than  the  threefold  suggested by the 
immunofluorescence experiments, it was necessary to arrest 
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FIGURE  16  Appearance of G  protein on the surface of interphase 
and mitotic NRK cells under conditions described in the legend to 
Figs. 10-13, except that incubation at 31 °C was carried oul in the 
presence or absence of 10 ~g/ml cycloheximide. For each stage of 
the  cell  cycle,  50-100  cells were  counted  and  scored  as  0  (no 
surface labeling) or 1 (detectable surface labeling) and the results 
were presented as a  percentage of the maximum possible score. 
Labeling  of internal G protein in a parallel experiment showed that 
>98% of the interphase  cells and >95% of those in mitosis were 
infected. Note that the occasional labeling of metaphase and ana- 
phase cells was always very faint. 
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FIGURE 17  Accessibility 
of G  protein to digestion 
by chymotrypsin in mitotic 
and G1 cells. The G protein 
was labeled and chased in 
the presence or absence of 
nocodazole and  the  cells 
were  then  treated  with 
chymotrypsin.  Samples 
were fractionated by SDS 
PAGE after extraction with 
Triton  X-114  and  the  la- 
beled proteins were visu- 
alized by fluorography. 
cells in mitosis. CHO cells can be arrested early in mitosis for 
up to  5  h  using  nocodazole,  and  >90%  of them  will  still 
complete mitosis upon removal of this drug (9). However, we 
found that after infection by VSV this time was reduced to 3 
h. To maximize use of this time window we infected the CHO 
cells in the roller bottle in the presence of nocodazole (0.04 
ug/rnl), and isolated the arrested mitotic cells 30 min later by 
rotation at 200 rpm for 3 min. We routinely obtained 1-3 x 
106 cells/roller bottle, of  which >95 % were infected and >90% 
were mitotic. Continued incubation in the presence of nocod- 
azole caused a  slight drop in the  mitotic index to 80-85%, 
whereas incubation in the absence of this drug allowed >95% 
of the  cells  to  enter  G~.  The  following  experiments were 
carried out. 
ACCESSIBILITY  OF  G  PROTEIN  TO  CHYMOTRYPSIN 
DIGESTION:  Infected mitotic cells,  released from nocoda- 
zole so that they could progress through to G~, were labeled 
using [35S]methionine  and then incubated for sufficient time 
to allow transport of the G  protein  to the  cell  surface.  As 
shown in Fig.  17, the G protein in these G~ cells was accessible 
to chymotrypsin, and  ~70%  of it was removed. A number 
of host cell proteins were still being synthesized at these early 
times after infection, so we confirmed the identity of the G 
protein  by  immunoprecipitation  using  specific  antibodies 
(data not shown). Comparable experiments using mitotic cells 
kept in  nocodazole showed that most of the G  protein was 
resistant  to  digestion  by chymotrypsin.  In  the  experiment 
shown in Fig.  17, only 20%  of the G  protein was removed. 
The molecular weight of the G  protein in these mitotic cells 
was also lower than that in the G~ cells, suggesting that it had 
not yet acquired complex oligosaccharides (18)  and had not 
therefore reached the Golgi complex. The inhibition of trans- 
port was not a side effect of nocodazole because transport to 
the  cell  surface of interphase cells was not  affected by this 
drug, though we routinely found that only 40-55% of the G 
protein was accessible to chymotrypsin compared with the 
70% found for G~ cells (Fig.  17). 
RELATIVE  QUANTITATION  OF  SURFACE  G  PROTEIN 
BY  IMMUNOELECTRON-MICROSCOPY"  At the end ofthe 2.5-h  incubation  in  the presence or absence of nocodazole, 
thin,  frozen sections of the cells were prepared for labeling 
with anti-G protein antibody and protein A gold. As shown 
in Fig.  18, there was very little surface label in mitotic cells 
compared with Gz cells. The surface labeling was quantitated 
by standard stereological techniques, with the additional ad- 
vantage that contaminating interphase cells in the mitotic cell 
samples were easily recognized and could be ignored. Table I 
shows the dramatic difference between mitotic and G, cells, 
the former having only 6% of the surface label of the latter. 
To control for possible side effects of nocodazole, interphase 
cells were treated in a comparable way with VSV and nocod- 
azole, and the presence of this drug was found to reduce the 
surface label to  70%  of the  original.  Taken together,  these 
results  point  to  at  least  a  10-fold  inhibition  of G  protein 
transport in mitotic cells. 
RATE OF VIRAL PROTEIN SYNTHESIS:  The conclusion 
just presented is valid only if the mitotic and G, cells synthe- 
sized similar amounts of viral protein. We had to show that 
the  absence  of surface  G  protein  in  mitotic  cells  was  not 
TABLE  I 
Quantitation of Surface G Protein in Mitotic and lnterphase 
Cells after 3 h of Infection 
Surface G  % of level with- 
Cell  Nocodazole  Protein*  out nocodazole 
Mitotic  +  0.25 _  0.09 
G~  -  4.10 _  0.37~  6 
Interphase  +  2.44 _+ 0.38 I. 
Interphase  -  3.50 _  0.35 J  70 
* Gold particles per intersection. There were ~3 intersections#tin.of plasma 
membrane and the results are expressed as the mean and standard error of 
the mean. For each condition  15 micrographs were used for counting. 
TABLE  II 
Effect of Nocodazole on the Rate of Viral Protein Synthesis in 
Mitotic and GI Clio Cells 
Cell  Nocodazole  Viral protein** 
Protein synthesized + 
nocodazole*/protein 
synthesized - 
nocodazole 
pg per 
cell~3 h 
Mitotic  +  1.4-3.7 ] 
t- 
G1  -  0.9-2.9.1 
1.0-I .4 
* Amount of G, L, N, NS, and M proteins synthesized after 3 h of infection. 
* The range of results was obtained from three experiments. 
simply the result of nocodazole inhibiting viral protein syn- 
thesis.  Some evidence  in  support  of this  has  already been 
provided (Fig.  17) but we also took samples for quantitative 
immunoblotting to determine the total amount of viral pro- 
tein  synthesized,  and  the  results are  presented  in  Table II. 
Despite some variation from experiment to experiment in the 
amount of viral protein synthesized, the ratio of the amount 
synthesized in the presence and absence of nocodazole in any 
single experiment showed clearly that, if anything, more pro- 
tein was synthesized in the presence of nocodazole, not less. 
FIGURE  18  Surface G  protein in CHO cells infected with VSV for 
3 h and either held in mitosis using nocodazole (a) or released from 
nocodazole to  give  G1  cells  (b).  The  thin,  frozen  sections  were 
labeled with anti-G protein antibodies followed by protein A gold. 
Bar, 0.2 ~m. x  70,000. 
DISCUSSION 
Mitotic  cells,  infected  with  VSV,  synthesize O  protein  but 
cannot transport it to the cell  surface, as determined by the 
lack of surface labeling by specific antibodies and inaccessi- 
bility of the  G  protein  to added  protease.  Nocodazole was 
used  in  most  of these  experiments to  arrest cells  early  in 
mitosis,  but  its  presence cannot  explain  the  inhibition  ob- 
served.  Not only did  this drug have no great effect on the 
appearance of cell surface O protein in interphase cells (Table 
2) but it also was absent from one of  the immunofluorescence 
experiments (Figs.  10-13) and the results were the same. A 
more serious objection is to the use of mitotic cells infected 
with  a  virus;  one  might  ask  whether  such  results  can  be 
generalized to host plasma membrane proteins. No definitive 
answer can yet be given, except that many pioneering studies 
of membrane biogenesis were made possible by the  use of 
virally infected interphase cells and that, so far, in no single 
instance is the viral envelope protein known to behave in a 
manner different from that of a cellular counterpart. 
The  10-fold  inhibition of intracellular transport is a mini- 
mum estimate that can be compared with the 30-fold inhibi- 
tion of endocytosis observed by Berlin and his colleagues (see 
reference 4). Endocytosis stops early in prophase and resumes 
in telophase (4).  Intracellular transport also resumes in telo- 
phase and it does not occur early in mitosis in cells arrested 
R^P,o COMMU~,C^'r,ONS  1627 by nocodazole. We cannot yet say whether it is inhibited early 
in prophase,  because the earliest time point  for observation 
in our immunofluorescence experiments was dictated by the 
time  taken for G  protein to reach the surface of interphase 
cells.  Prophase cells would  have progressed  through to,  say, 
metaphase in this time, and the observed surface labeling of 
prophase cells in our experiments (Fig.  16) presumably  rep- 
resented late G2 ceils that had had sufficient time to express 
surface G  before entering mitosis. 
The  inhibition  of intracellular  transport  and  endocytosis 
(4)  point  to  a  general  cessation  of vesicular  traffic  during 
mitosis, and it is not unreasonable to think that a  common 
mechanism is responsible for this inhibition.  The effect is so 
dramatic and unexpected  that it warrants further study, and 
our present  efforts  are  aimed  at  confirming  the  suggestion 
(Fig.  17)  that  the G  protein  is  not transported  through the 
Golgi complex in mitotic cells. 
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